Slow dose reduction over 4-6 weeks allows your appetite-regulating neurons to adjust incrementally, potentially reducing the intensity of hunger rebound
Delayed gastric emptying : These medications slow the rate at which food leaves the stomach, promoting satiety and reducing postprandial glucose spikes
GHRP-2 is commonly used in controlled in-vitro and preclinical research models investigating receptor binding and endocrine signaling
Consequently, the American Society of Anesthesiologists has published a consensus-based guidance on perioperative management of GLP1-RAs, recommending holding daily doses of once-daily GLP1-RAs on the day of surgery and of once weekly dosing one week prior to surgery, ensuring at least one-week cessation of long-acting GLP1-RAs [10]
Both variations of GLP-1s work by mimicking a hormone normally produced by the gut after a meal, effectively tricking the hunger impulse and offering support to prevent overeating
Contraindications and precautions include personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, history of pancreatitis (requires careful consideration), severe gastrointestinal disease, diabetic retinopathy (requires caution), and pregnancy or planned pregnancy
